𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy

✍ Scribed by Nicolai Sidenius; Francesco Blasi

Book ID
110432658
Publisher
Springer
Year
2003
Tongue
English
Weight
159 KB
Volume
22
Category
Article
ISSN
0167-7659

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The urokinase-type plasminogen activator
The urokinase-type plasminogen activator system in cancer metastasis: A review
✍ Peter A. Andreasen; Lars KjΓΈller; Lise Christensen; Michael J. Duffy πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 398 KB πŸ‘ 1 views

The urokinase-type plasminogen activator (u-PA) system consists of the serine proteinases plasmin and u-PA; the serpin inhibitors a 2 -anti-plasmin, PAI-1 and PAI-2; and the u-PA receptor (u-PAR). Two lines of evidence have strongly suggested an important and apparently causal role for the u-PA syst

The insulin-like growth factor-1 elevate
The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy
✍ S.E. Dunn; J.V. Torres; N. Nihei; J.C. Barrett πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su